In summary, our data suggest that Ku80 expression level could predict the outcome and the sensitivity to cisplatin-based chemotherapy in patients with lung adenocarcima. Ku80 knockdown increases the sensitivity of cisplatin resistant human lung Wortmannin chemical structure adenocarcinoma cells to cisplatin in vitro. Therefore, Ku80 has the potential to serve as a biomarker for the prediction of cisplatin response and represent a promising target for the combination of cisplatin-based chemotherapy in patients with lung adenocarcinoma. Acknowledgments This work was supported by the
National Natural Science Foundation of China (No. 30971315) and the Science & Technology Development Planning Project of Jilin Province (No. 200905147 and 200705236). References 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69–90.PubMedCrossRef
2. Fan Z, this website Schraeder R: click here The changing pathology of lung cancer. Surg Oncol Clin N Am 2011, 20:637–653.PubMedCrossRef 3. Azzoli CG, Baker S, Temin S, Pao W, Aliff T, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, et al.: American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV Non-small-cell lung cancer. J Clin Oncol 2009, 27:6251–6266.PubMedCrossRef 4. Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O’Connell M, Shepherd FA, Johnson BE: Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 2001, 19:1734–1742.PubMed 5. Suzuki K, Kodama S, Watanabe M: Role of Ku80-dependent end-joining in delayed genomic instability in mammalian cells surviving ionizing radiation. Mutat Res 2010, 683:29–34.PubMedCrossRef 6. Postow L, Ghenoiu C, Woo EM, Krutchinsky AN, Chait BT, Funabiki H: Ku80 removal from DNA through double strand break-induced ubiquitylation. J Cell Biol 2008, 182:467–479.PubMedCrossRef 7. Wang HC, Liu CS, Chiu CF, Chiang SY, Wang CH, Wang RF, Lin CC, Tsai RY, Bau DT: Significant association of DNA repair
gene Ku80 genotypes with breast cancer susceptibility in Taiwan. Anticancer Niclosamide Res 2009, 29:5251–5254.PubMed 8. Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J: Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer 2008, 112:2756–2764.PubMedCrossRef 9. Pucci S, Mazzarelli P, Rabitti C, Giai M, Gallucci M, Flammia G, Alcini A, Altomare V, Fazio VM: Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 2001, 20:739–747.PubMedCrossRef 10. Ye J, Ren ZY, Gu Q, Wang LM, Wang JL: Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice. DNA Cell Biol 2011, 30:987–994.